Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?

Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?

One of the main aims in the management of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency is to achieve adequate suppression of the adrenal cortex with the smallest possible dose of glucocorticoid substitution. To evaluate the administration schedule of current replacem...

Bibliografiset tiedot
Päätekijät:	Charmandari, E, Matthews, D, Johnston, A, Brook, C, Hindmarsh, P
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2001

Samankaltaisia teoksia

Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency.
Tekijä: Charmandari, E, et al.
Julkaistu: (2003)

Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Tekijä: Charmandari, E, et al.
Julkaistu: (2002)

Adrenal adenoma secreting 17-hydroxyprogesterone mimicking non-classical 21-hydroxylase deficiency
Tekijä: Beata Woźniak, et al.
Julkaistu: (2024-11-01)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
Tekijä: Tomoyo Itonaga, et al.
Julkaistu: (2022-01-01)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
Tekijä: Mark R de Hora, et al.
Julkaistu: (2020-01-01)

Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.
Tekijä: Peters, C, et al.
Julkaistu: (2013)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
Tekijä: Nicole L.B. Corder-Ramos, et al.
Julkaistu: (2019-08-01)

Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
Tekijä: Analia Yogi, et al.
Julkaistu: (2023-10-01)

Method Development and Clinical Utility for Simultaneous Measurement of 21-Deoxycortisol, 17-Hydroxyprogesterone, Cortisol, and Cortisone Levels in Human Plasma Using UHPLC-MS/MS
Tekijä: Syed N. Alvi, et al.
Julkaistu: (2025-01-01)

21-Hydroxylase deficiency in Brazil
Tekijä: T.A.S.S. Bachega, et al.
Julkaistu: (2000-10-01)

Dexamethasone application for in vitro fertilisation in non-classic 17-hydroxylase/17,20-lyase-deficient women
Tekijä: Xiu-Li Yang, et al.
Julkaistu: (2022-10-01)

Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than in their male counterparts.
Tekijä: Charmandari, E, et al.
Julkaistu: (2001)

Effectiveness of 17-Alpha-Hydroxyprogesterone in the Prevention of Preterm Labour
Tekijä: Uzma Urooj, et al.
Julkaistu: (2023-03-01)

Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
Tekijä: Helmuth G. Dörr, et al.
Julkaistu: (2018-11-01)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
Tekijä: Helmuth G. Dörr, et al.
Julkaistu: (2018-06-01)

NON CLASSIC 21 HYDROXYLASE DEFICIENT ADRENAL HYPERPLASIA IN PATIENTS WITH ISOLATED PRECOCIOUS PUBARCHE
Tekijä: H. Moayeri, et al.
Julkaistu: (2003-09-01)

NON CLASSIC 21 HYDROXYLASE DEFICIENT ADRENAL HYPERPLASIA IN PATIENTS WITH ISOLATED PRECOCIOUS PUBARCHE
Tekijä: H. Moayeri, et al.
Julkaistu: (2003-07-01)

Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases
Tekijä: Claire M. Hull, et al.
Julkaistu: (2017-09-01)

Adrenal Morphology as an Indicator of Long-Term Disease Control in Adults with Classic 21-Hydroxylase Deficiency
Tekijä: Taek Min Kim, et al.
Julkaistu: (2022-02-01)

Clinical Profile, Predictors of Death and Anthropometric Follow up in Neonates with Classical 21-Hydroxylase Deficiency
Tekijä: Usha Devi Rajendran, et al.
Julkaistu: (2018-05-01)

Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency
Tekijä: Liat de Vries, et al.
Julkaistu: (2019-10-01)

Flash glucose monitoring system was applied to cortisol treatment for a patient with congenital adrenal hyperplasia and 17α-hydroxylase deficiency
Tekijä: Chenyu Xiang, et al.
Julkaistu: (2020-09-01)

Production and Scale-Up of a Monoclonal Antibody Against 17-Hydroxyprogesterone
Tekijä: Chua, Gek Kee, et al.
Julkaistu: (2013)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
Tekijä: Carla E. Ransom, et al.
Julkaistu: (2011-01-01)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
Tekijä: Claudia Teti, et al.
Julkaistu: (2023-05-01)

Influence of sample quality on phenylalanine and 17-hydroxyprogesterone levels in neonatal screening
Tekijä: Lesley del Río Fabre, et al.

Female pseudohermaphroditism due to classical 21-hydroxylase deficiency and insulin resistance in a girl with Turner syndrome
Tekijä: M Emre Atabek, et al.
Julkaistu: (2005-04-01)

Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Tekijä: T P Ajish, et al.
Julkaistu: (2014-01-01)

Analysis of the Influencing Factors of 17-Hydroxyprogesterone Level and the Correlation between 17-Hydroxyprogesterone Level and the Clinical Parameters Related to Adrenal Cortical Function in Very-Low-Birth-Weight Infants
Tekijä: Chang Dae Kum, et al.
Julkaistu: (2019-02-01)

Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation
Tekijä: Ronda F. Greaves, et al.
Julkaistu: (2023-10-01)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Tekijä: Larissa G. Gomes, et al.
Julkaistu: (2013-01-01)

Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Tekijä: Ricardo P. P. Moreira, et al.
Julkaistu: (2011-01-01)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
Tekijä: Morrison John J, et al.
Julkaistu: (2004-12-01)

New insights on hyperglycemia in 17-hydroxylase/17,20-lyase deficiency
Tekijä: Lingling Xu, et al.
Julkaistu: (2022-07-01)

Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy
Tekijä: Preet K. Matharu, et al.
Julkaistu: (2022-10-01)

Clinical characteristics and treatment during preconception and perinatal period of infertile women with non-classical 21-hydroxylase deficiency
Tekijä: Xuejiao Cui, et al.
Julkaistu: (2024-10-01)

Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency.
Tekijä: Ricardo P P Moreira, et al.
Julkaistu: (2012-01-01)

Non-Classical 21-Hydroxylase Deficiency: Analysis of a Mutant Gene in a Uyghur Family and Literature Review
Tekijä: Maimaitiming J, et al.
Julkaistu: (2021-04-01)

Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Tekijä: Seung Gyun Lim, et al.
Julkaistu: (2021-10-01)

Two Adults with Adrenal Myelolipoma and 21-Hydroxylase Deficiency
Tekijä: Ingrid Nermoen, et al.
Julkaistu: (2009-01-01)